Global Personalized Tumor Vaccines Market Insights, Forecast to 2031

TABLE OF CONTENTS

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Personalized Tumor Vaccines Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
  • 1.2.2 DNA-based
  • 1.2.3 RNA-based
• 1.3 Market by Application
  • 1.3.1 Global Personalized Tumor Vaccines Market Share by Application: 2020 VS 2024 VS 2031
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Personalized Tumor Vaccines Market Perspective (2020-2031)
• 2.2 Global Personalized Tumor Vaccines Growth Trends by Region
  • 2.2.1 Global Personalized Tumor Vaccines Market Size by Region: 2020 VS 2024 VS 2031
  • 2.2.2 Personalized Tumor Vaccines Market Size by Region (2020-2031)
• 2.3 Personalized Tumor Vaccines Market Dynamics
  • 2.3.1 Personalized Tumor Vaccines Industry Trends
  • 2.3.2 Personalized Tumor Vaccines Market Drivers
  • 2.3.3 Personalized Tumor Vaccines Market Challenges
  • 2.3.4 Personalized Tumor Vaccines Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Revenue Personalized Tumor Vaccines by Players
  • 3.1.1 Global Personalized Tumor Vaccines Revenue by Players (2020-2025)
  • 3.1.2 Global Personalized Tumor Vaccines Revenue Market Share by Players (2020-2025)
• 3.2 Global Personalized Tumor Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Global Key Players of Personalized Tumor Vaccines, Ranking by Revenue, 2023 VS 2024 VS 2025
• 3.4 Global Market Concentration Ratio
  • 3.4.1 Global Personalized Tumor Vaccines Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Personalized Tumor Vaccines Revenue in 2024
• 3.5 Global Key Players of Personalized Tumor Vaccines Head office and Area Served
• 3.6 Global Key Players of Personalized Tumor Vaccines, Product and Application
• 3.7 Global Key Players of Personalized Tumor Vaccines, Date of Enter into This Industry
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type

• 4.1 Global Personalized Tumor Vaccines Historic Market Size by Type (2020-2025)
• 4.2 Global Personalized Tumor Vaccines Forecasted Market Size by Type (2026-2031)

5 Breakdown Data by Application

• 5.1 Global Personalized Tumor Vaccines Historic Market Size by Application (2020-2025)
• 5.2 Global Personalized Tumor Vaccines Forecasted Market Size by Application (2026-2031)

6 North America

• 6.1 North America Personalized Tumor Vaccines Market Size (2020-2031)
• 6.2 North America Market Size by Type
  • 6.2.1 North America Personalized Tumor Vaccines Market Size by Type (2020-2031)
  • 6.2.2 North America Personalized Tumor Vaccines Market Share by Type (2020-2031)
• 6.3 North America Market Size by Application
  • 6.3.1 North America Personalized Tumor Vaccines Market Size by Application (2020-2031)
  • 6.3.2 North America Personalized Tumor Vaccines Market Share by Application (2020-2031)
• 6.4 North America Market Size by Country
  • 6.4.1 North America Personalized Tumor Vaccines Market Size by Country: 2020 VS 2024 VS 2031
  • 6.4.2 North America Personalized Tumor Vaccines Market Size by Country (2020-2031)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Personalized Tumor Vaccines Market Size (2020-2031)
• 7.2 Europe Market Size by Type
  • 7.2.1 Europe Personalized Tumor Vaccines Market Size by Type (2020-2031)
  • 7.2.2 Europe Personalized Tumor Vaccines Market Share by Type (2020-2031)
• 7.3 Europe Market Size by Application
  • 7.3.1 Europe Personalized Tumor Vaccines Market Size by Application (2020-2031)
  • 7.3.2 Europe Personalized Tumor Vaccines Market Share by Application (2020-2031)
• 7.4 Europe Market Size by Country
  • 7.4.1 Europe Personalized Tumor Vaccines Market Size by Country: 2020 VS 2024 VS 2031
  • 7.4.2 Europe Personalized Tumor Vaccines Market Size by Country (2020-2025)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 China

• 8.1 China Personalized Tumor Vaccines Market Size (2020-2031)
• 8.2 China Market Size by Type
  • 8.2.1 China Personalized Tumor Vaccines Market Size by Type (2020-2031)
  • 8.2.2 China Personalized Tumor Vaccines Market Share by Type (2020-2031)
• 8.3 China Market Size by Application
  • 8.3.1 China Personalized Tumor Vaccines Market Size by Application (2020-2031)
  • 8.3.2 China Personalized Tumor Vaccines Market Share by Application (2020-2031)

9 Asia (excluding China)

• 9.1 Asia Personalized Tumor Vaccines Market Size (2020-2031)
• 9.2 Asia Market Size by Type
  • 9.2.1 Asia Personalized Tumor Vaccines Market Size by Type (2020-2031)
  • 9.2.2 Asia Personalized Tumor Vaccines Market Share by Type (2020-2031)
• 9.3 Asia Market Size by Application
  • 9.3.1 Asia Personalized Tumor Vaccines Market Size by Application (2020-2031)
  • 9.3.2 Asia Personalized Tumor Vaccines Market Share by Application (2020-2031)
• 9.4 Asia Market Size by Region
  • 9.4.1 Asia Personalized Tumor Vaccines Market Size by Region: 2020 VS 2024 VS 2031
  • 9.4.2 Asia Personalized Tumor Vaccines Market Size by Region (2020-2031)
  • 9.4.3 Japan
  • 9.4.4 South Korea
  • 9.4.5 China Taiwan
  • 9.4.6 Southeast Asia
  • 9.4.7 India
  • 9.4.8 Australia

10 Middle East, Africa, and Latin America

• 10.1 Middle East, Africa, and Latin America Personalized Tumor Vaccines Market Size (2020-2031)
• 10.2 Middle East, Africa, and Latin America Market Size by Type
  • 10.2.1 Middle East, Africa, and Latin America Personalized Tumor Vaccines Market Size by Type (2020-2031)
  • 10.2.2 Middle East, Africa, and Latin America Personalized Tumor Vaccines Market Share by Type (2020-2031)
• 10.3 Middle East, Africa, and Latin America Market Size by Application
  • 10.3.1 Middle East, Africa, and Latin America Personalized Tumor Vaccines Market Size by Application (2020-2031)
  • 10.3.2 Middle East, Africa, and Latin America Market Share by Application (2020-2031)
• 10.4 Middle East, Africa, and Latin America Market Size by Country
  • 10.4.1 Middle East, Africa, and Latin America Personalized Tumor Vaccines Market Size by Country: 2020 VS 2024 VS 2031
  • 10.4.2 Middle East, Africa, and Latin America Personalized Tumor Vaccines Market Size by Country (2020-2031)
  • 10.4.3 Brazil
  • 10.4.4 Mexico
  • 10.4.5 Turkey
  • 10.4.6 Saudi Arabia
  • 10.4.7 Israel
  • 10.4.8 GCC Countries

11 Key Players Profiles

• 11.1 Geneos Therapeutics
  • 11.1.1 Geneos Therapeutics Company Details
  • 11.1.2 Geneos Therapeutics Business Overview
  • 11.1.3 Geneos Therapeutics Personalized Tumor Vaccines Introduction
  • 11.1.4 Geneos Therapeutics Revenue in Personalized Tumor Vaccines Business (2020-2025)
  • 11.1.5 Geneos Therapeutics Recent Development
• 11.2 BioNTech
  • 11.2.1 BioNTech Company Details
  • 11.2.2 BioNTech Business Overview
  • 11.2.3 BioNTech Personalized Tumor Vaccines Introduction
  • 11.2.4 BioNTech Revenue in Personalized Tumor Vaccines Business (2020-2025)
  • 11.2.5 BioNTech Recent Development
• 11.3 Siemens
  • 11.3.1 Siemens Company Details
  • 11.3.2 Siemens Business Overview
  • 11.3.3 Siemens Personalized Tumor Vaccines Introduction
  • 11.3.4 Siemens Revenue in Personalized Tumor Vaccines Business (2020-2025)
  • 11.3.5 Siemens Recent Development
• 11.4 Moderna
  • 11.4.1 Moderna Company Details
  • 11.4.2 Moderna Business Overview
  • 11.4.3 Moderna Personalized Tumor Vaccines Introduction
  • 11.4.4 Moderna Revenue in Personalized Tumor Vaccines Business (2020-2025)
  • 11.4.5 Moderna Recent Development
• 11.5 Merck
  • 11.5.1 Merck Company Details
  • 11.5.2 Merck Business Overview
  • 11.5.3 Merck Personalized Tumor Vaccines Introduction
  • 11.5.4 Merck Revenue in Personalized Tumor Vaccines Business (2020-2025)
  • 11.5.5 Merck Recent Development
• 11.6 Everest Medicines
  • 11.6.1 Everest Medicines Company Details
  • 11.6.2 Everest Medicines Business Overview
  • 11.6.3 Everest Medicines Personalized Tumor Vaccines Introduction
  • 11.6.4 Everest Medicines Revenue in Personalized Tumor Vaccines Business (2020-2025)
  • 11.6.5 Everest Medicines Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
    • 13.1.1.1 Research Programs/Design
    • 13.1.1.2 Market Size Estimation
    • 13.1.1.3 Market Breakdown and Data Triangulation
  • 13.1.2 Data Source
    • 13.1.2.1 Secondary Sources
    • 13.1.2.2 Primary Sources
• 13.2 Author Details
• 13.3 Disclaimer

List of Tables

Table 1. Global Personalized Tumor Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of DNA-based

Table 3. Key Players of RNA-based

Table 4. Global Personalized Tumor Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Personalized Tumor Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Market Size by Region (2020-2031) & (US$ Million)

Table 7. Global Personalized Tumor Vaccines Market Share by Region (2020-2031)

Table 8. Market Trends

Table 9. Market Drivers

Table 10. Market Challenges

Table 11. Market Restraints

Table 12. Global Personalized Tumor Vaccines Revenue by Players (2020-2025) & (US$ Million)

Table 13. Global Personalized Tumor Vaccines Market Share by Players (2020-2025)

Table 14. Global Top Personalized Tumor Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Tumor Vaccines as of 2024)

Table 15. Global Personalized Tumor Vaccines Industry Ranking 2023 VS 2024

Table 16. Global 5 Largest Players Market Share by Personalized Tumor Vaccines Revenue (CR5 and HHI) & (2020-2025)

Table 17. Global Key Players of Personalized Tumor Vaccines, Headquarters and Area Served

Table 18. Global Key Players of Personalized Tumor Vaccines, Product and Application

Table 19. Global Key Players of Personalized Tumor Vaccines, Date of Enter into This Industry

Table 20. Mergers & Acquisitions, Expansion Plans

Table 21. Global Market Size by Type (2020-2025) & (US$ Million)

Table 22. Global Personalized Tumor Vaccines Revenue Market Share by Type (2020-2025)

Table 23. Global Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 24. Global Personalized Tumor Vaccines Revenue Market Share by Type (2026-2031)

Table 25. Global Market Size by Application (2020-2025) & (US$ Million)

Table 26. Global Personalized Tumor Vaccines Revenue Market Share by Application (2020-2025)

Table 27. Global Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 28. Global Personalized Tumor Vaccines Revenue Market Share by Application (2026-2031)

Table 29. North America Market Size by Type (2020-2031) & (US$ Million)

Table 30. North America Market Size by Application (2020-2031) & (US$ Million)

Table 31. North America Personalized Tumor Vaccines Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Market Size by Country (2020-2031) & (US$ Million)

Table 33. Europe Market Size by Type (2020-2031) & (US$ Million)

Table 34. Europe Market Size by Application (2020-2031) & (US$ Million)

Table 35. Europe Personalized Tumor Vaccines Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Market Size by Country (2020-2025) & (US$ Million)

Table 37. China Market Size by Type (2020-2031) & (US$ Million)

Table 38. China Market Size by Application (2020-2031) & (US$ Million)

Table 39. Asia Market Size by Type (2020-2031) & (US$ Million)

Table 40. Asia Market Size by Application (2020-2025) & (US$ Million)

Table 41. Asia Personalized Tumor Vaccines Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031

Table 42. Asia Market Size by Region (2020-2031) & (US$ Million)

Table 43. Middle East, Africa, and Latin America Market Size by Type (2020-2031) & (US$ Million)

Table 44. Middle East, Africa, and Latin America Market Size by Application (2020-2031) & (US$ Million)

Table 45. Middle East, Africa, and Latin America Personalized Tumor Vaccines Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East, Africa, and Latin America Market Size by Country (2020-2031) & (US$ Million)

Table 47. Geneos Therapeutics Company Details

Table 48. Geneos Therapeutics Business Overview

Table 49. Geneos Therapeutics Personalized Tumor Vaccines Product

Table 50. Geneos Therapeutics Revenue (2020-2025) & (US$ Million)

Table 51. Geneos Therapeutics Recent Development

Table 52. BioNTech Company Details

Table 53. BioNTech Business Overview

Table 54. BioNTech Personalized Tumor Vaccines Product

Table 55. BioNTech Revenue (2020-2025) & (US$ Million)

Table 56. BioNTech Recent Development

Table 57. Siemens Company Details

Table 58. Siemens Business Overview

Table 59. Siemens Personalized Tumor Vaccines Product

Table 60. Siemens Revenue (2020-2025) & (US$ Million)

Table 61. Siemens Recent Development

Table 62. Moderna Company Details

Table 63. Moderna Business Overview

Table 64. Moderna Personalized Tumor Vaccines Product

Table 65. Moderna Revenue (2020-2025) & (US$ Million)

Table 66. Moderna Recent Development

Table 67. Merck Company Details

Table 68. Merck Business Overview

Table 69. Merck Personalized Tumor Vaccines Product

Table 70. Merck Revenue (2020-2025) & (US$ Million)

Table 71. Merck Recent Development

Table 72. Everest Medicines Company Details

Table 73. Everest Medicines Business Overview

Table 74. Everest Medicines Personalized Tumor Vaccines Product

Table 75. Everest Medicines Revenue (2020-2025) & (US$ Million)

Table 76. Everest Medicines Recent Development

Table 77. Research Programs/Design for This Report

Table 78. Key Data Information from Secondary Sources

Table 79. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Personalized Tumor Vaccines Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 2. Global Personalized Tumor Vaccines Market Share by Type: 2024 VS 2031

Figure 3. DNA-based Features

Figure 4. RNA-based Features

Figure 5. Global Personalized Tumor Vaccines Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Global Personalized Tumor Vaccines Market Share by Application: 2024 VS 2031

Figure 7. Hospital Case Studies

Figure 8. Clinic Case Studies

Figure 9. Others Case Studies

Figure 10. Personalized Tumor Vaccines Report Years Considered

Figure 11. Global Personalized Tumor Vaccines Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Personalized Tumor Vaccines Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Personalized Tumor Vaccines Market Share by Region: 2024 VS 2031

Figure 14. Global Personalized Tumor Vaccines Market Share by Players in 2024

Figure 15. Global Top Personalized Tumor Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Tumor Vaccines as of 2024)

Figure 16. The Top 10 and 5 Players Market Share by Personalized Tumor Vaccines Revenue in 2024

Figure 17. North America Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 18. North America Personalized Tumor Vaccines Market Share by Type (2020-2031)

Figure 19. North America Personalized Tumor Vaccines Market Share by Application (2020-2031)

Figure 20. North America Personalized Tumor Vaccines Market Share by Country (2020-2031)

Figure 21. United States Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Personalized Tumor Vaccines Market Share by Type (2020-2031)

Figure 25. Europe Personalized Tumor Vaccines Market Share by Application (2020-2031)

Figure 26. Europe Personalized Tumor Vaccines Market Share by Country (2020-2031)

Figure 27. Germany Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. China Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. China Personalized Tumor Vaccines Market Share by Type (2020-2031)

Figure 35. China Personalized Tumor Vaccines Market Share by Application (2020-2031)

Figure 36. Asia Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Asia Personalized Tumor Vaccines Market Share by Type (2020-2031)

Figure 38. Asia Personalized Tumor Vaccines Market Share by Application (2020-2031)

Figure 39. Asia Personalized Tumor Vaccines Market Share by Region (2020-2031)

Figure 40. Japan Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. South Korea Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. China Taiwan Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Southeast Asia Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. India Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Australia Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Personalized Tumor Vaccines Market Share by Type (2020-2031)

Figure 48. Middle East, Africa, and Latin America Personalized Tumor Vaccines Market Share by Application (2020-2031)

Figure 49. Middle East, Africa, and Latin America Personalized Tumor Vaccines Market Share by Country (2020-2031)

Figure 50. Brazil Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Mexico Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Turkey Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. Israel Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. GCC Countries Personalized Tumor Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. Geneos Therapeutics Revenue Growth Rate in Personalized Tumor Vaccines Business (2020-2025)

Figure 57. BioNTech Revenue Growth Rate in Personalized Tumor Vaccines Business (2020-2025)

Figure 58. Siemens Revenue Growth Rate in Personalized Tumor Vaccines Business (2020-2025)

Figure 59. Moderna Revenue Growth Rate in Personalized Tumor Vaccines Business (2020-2025)

Figure 60. Merck Revenue Growth Rate in Personalized Tumor Vaccines Business (2020-2025)

Figure 61. Everest Medicines Revenue Growth Rate in Personalized Tumor Vaccines Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed